中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2014年
3期
416-417,419
,共3页
血液稀释%低分子肝素%短暂性脑缺血
血液稀釋%低分子肝素%短暫性腦缺血
혈액희석%저분자간소%단잠성뇌결혈
Hemodilution%Low molecular heparin%Transient ischemic attack
目的:观察血液稀释联合低分子肝素治疗短暂性脑缺血发作(TIA)的可行性。方法:将72例TIA病人随机分成两组,治疗组给予低分子右旋糖苷250ml静滴,同时皮下注射低分子肝素钙5000u,2次/d,连用10d;对照组按医嘱常规治疗。治疗10d后,进行临床疗效评定及化验指标观察。结果:治疗组总有效率为93.75%,对照组总有效率为76.66%,两组比较差异有统计学意义(P<0.05)。治疗组治疗后血小板计数、全血高切黏度、血浆黏度均较治疗前、治疗后对照组明显降低,差异有统计学意义(P<0.05)。结论:血液稀释疗法联合低分子肝素更有利于阻止TIA患者病情进展、促进神经功能恢复,而且安全、可靠。
目的:觀察血液稀釋聯閤低分子肝素治療短暫性腦缺血髮作(TIA)的可行性。方法:將72例TIA病人隨機分成兩組,治療組給予低分子右鏇糖苷250ml靜滴,同時皮下註射低分子肝素鈣5000u,2次/d,連用10d;對照組按醫囑常規治療。治療10d後,進行臨床療效評定及化驗指標觀察。結果:治療組總有效率為93.75%,對照組總有效率為76.66%,兩組比較差異有統計學意義(P<0.05)。治療組治療後血小闆計數、全血高切黏度、血漿黏度均較治療前、治療後對照組明顯降低,差異有統計學意義(P<0.05)。結論:血液稀釋療法聯閤低分子肝素更有利于阻止TIA患者病情進展、促進神經功能恢複,而且安全、可靠。
목적:관찰혈액희석연합저분자간소치료단잠성뇌결혈발작(TIA)적가행성。방법:장72례TIA병인수궤분성량조,치료조급여저분자우선당감250ml정적,동시피하주사저분자간소개5000u,2차/d,련용10d;대조조안의촉상규치료。치료10d후,진행림상료효평정급화험지표관찰。결과:치료조총유효솔위93.75%,대조조총유효솔위76.66%,량조비교차이유통계학의의(P<0.05)。치료조치료후혈소판계수、전혈고절점도、혈장점도균교치료전、치료후대조조명현강저,차이유통계학의의(P<0.05)。결론:혈액희석요법연합저분자간소경유리우조지TIA환자병정진전、촉진신경공능회복,이차안전、가고。
Objective: To observe the clinical curative effect of hemodilution combination of low molecular heparin in the treatment of transient ischemic attack(TIA). Methods:72 cases with TIA were randomly divided into two groups.The treatment group were intravenous drip injected with 250ml low molecular dextran once a day,and subcutaneously injected with 5000iu low molecular heparin twice a day for 10 days.The control group was conventional treament. after treatment 10 day, assessment of clinical efficacy and laboratory indicators was observed. Results:The prostecdtive efficacy of the treatment group (totai effective was 93.75%) was better than that of the control group (totai effective was 76.66%),and the significant effective power of nervous functional rehabilitation in the treatment group was much higher than that of the control group(P<0.05).The after treatment of treatment group, the platelet count, high shear blood viscosity, plasma viscosity than that before treatment, and control group after treatment was significantly decreased, the difference was statistically significant (P<0.05).Conclusion:The treatment of hemodilution combination of low molecular heparin was favorable for stopping the advancement of stroke and promoting the recovery of nerves function.It was safe and suitable for the early application.